Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexagliflozin vs Glimepiride in T2DM
NCT02769481Phase 3Completed
- Sponsor
- Theracos, Inc.
- Start
- Aug 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of bexagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Theracos, Inc.. Started Aug 2016; status: completed.
02
Drugs
bexagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02769481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769481.